Asie · Bourse & Finance · The Economic Times

Reliance Retail faces fresh FDA action

Publié par The Economic Times · Inde il y a 1 h

Mumbai: The Maharashtra Food and Drug Administration (FDA) has taken action against Reliance Retail for the second consecutive day on Sunday, suspending the licences of its…

Lire l'article complet sur The Economic Times Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (economictimes.indiatimes.com)

Reliance Retail faces fresh FDA action

À lire aussi

What’s next for IDBI Bank stock after Q2 net profit slumps 39%, massive Fairfax deal? Key factors investors should watch

The AI promise was automation. The reality? Managing digital workers

Nifty Outlook For October 19: Factors remain in place for recovery to continue in truncated week

คะแนนนิยมรัฐบาลทาคาอิจิร่วงแตะต่ำสุดเป็นประวัติการณ์ ท่ามกลางข่าวฉาวรมว.เกษตร

Mapping the noteworthy startups in China’s health sector

AI could make it harder for freshers to land tech jobs, Anthropic report warns

Reliance Retail faces fresh FDA action

Partager

À lire aussi

What’s next for IDBI Bank stock after Q2 net profit slumps 39%, massive Fairfax deal? Key factors investors should watch

The AI promise was automation. The reality? Managing digital workers

Nifty Outlook For October 19: Factors remain in place for recovery to continue in truncated week

คะแนนนิยมรัฐบาลทาคาอิจิร่วงแตะต่ำสุดเป็นประวัติการณ์ ท่ามกลางข่าวฉาวรมว.เกษตร

Mapping the noteworthy startups in China’s health sector

AI could make it harder for freshers to land tech jobs, Anthropic report warns